Gut microbe molecule reveals molecular link between microbiome and whole-body metabolism
· Medical Xpressedited by Gaby Clark, reviewed by Robert Egan
Gaby Clark
Scientific Editor
Meet our editorial team
Behind our editorial process
Robert Egan
Senior Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
The GIST Add as preferred source
Researchers at the University of Konstanz have demonstrated at a molecular level how bacteria in the human gut influence the entire body. Among other things, they can lower blood sugar levels and reduce fatty liver disease. The work is published in the journal EMBO Molecular Medicine.
For several years, a wide range of over-the-counter products designed to have a positive effect on the gut microbiome have been available. They promise greater bacterial diversity in the digestive tract and, as a result, better overall health. For the same purpose, doctors prescribe medications aimed at restoring gut microbial balance, for instance, following antibiotic treatment.
But why does the gut microbiota have such a profound impact on the entire organism? Thomas Brunner, professor of biochemical pharmacology, and biologist Anna Pia Plazzo at the University of Konstanz set out to answer this question. Together with their team, they recently discovered that gut bacteria and the compounds they produce—which also enter the food chain via ruminants—trigger biological processes that the human body can activate only with difficulty. They help suppress inflammation and may also have beneficial effects on fatty liver disease.
The search for LRH-1's ligand
In his research, Brunner investigated a specific transcription factor, the nuclear receptor LRH-1/NR5A2. This receptor plays an important role in regulating inflammatory and metabolic diseases and also influences tumor development. However, to carry out its functions, it must first be "activated." This activation occurs when specific molecules known as ligands bind to the receptor.
More than two decades ago, researchers discovered that the LRH-1 receptor is present in the intestine and liver. Yet the ligand responsible for its activation remained elusive. This raised an important question: What activates LRH-1 in these organs?
"For many nuclear receptors, the ligands required are known, such as thyroid hormones. These receptors can be specifically regulated or activated. LRH-1, however, does not have a clearly defined ligand produced by the body. And if it doesn't come from the body itself, the source is likely another resident of the gut: its bacterial community," Brunner explains.
Vaccenic acid activates the receptor
Through a series of experiments and analyses, he and his team eventually found that probiotic bacteria do indeed produce molecules that act as ligands for the LRH-1 receptor. The key substance is vaccenic acid, which is not naturally present in the human body.
"Vaccenic acid is produced by bacteria that live in ruminants. During the rumination process, the bacteria generate this fatty acid, which is subsequently distributed throughout the animal's body, including its muscle tissue and milk. When we consume foods such as meat and dairy products from ruminants, vaccenic acid reaches our intestine, where it can continue to exert its beneficial effects," Brunner explains.
Further experiments in mice revealed that vaccenic acid can improve a variety of health-related markers. Blood sugar and blood lipid levels fell significantly in the tests, and an existing fatty liver condition improved.
"The administration of vaccenic acid ultimately has a therapeutic effect on the body's entire metabolism, as it activates the transcription factor LRH-1," Brunner says, summarizing the findings.
For the first time, the researchers identified a bacterial ligand capable of activating the transcription factor LRH-1. Yet, according to Brunner, their study illustrates even more: "An imbalance in the gut microbiome may have a huge impact on the whole body. Our research shows, at the molecular level, how an intact microbiome releases substances that regulate physiological processes in the body and thus positively influence overall metabolism."
Publication details
Anna Pia Plazzo et al, Microbiome-host communication via vaccenic acid modulates LRH-1/NR5A2 activity and ameliorates metabolic liver disease, EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00516-3
Journal information: EMBO Molecular Medicine
Key medical concepts
Clinical categories
GastroenterologyEndocrinologyDigestive healthCommon illnesses & Prevention Provided by University of Konstanz Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Gut microbe molecule reveals molecular link between microbiome and whole-body metabolism (2026, September 17) retrieved 17 September 2026 from https://medicalxpress.com/news/2026-09-gut-microbe-molecule-reveals-molecular.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.